Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1981 Nov;44(5):725-32.
doi: 10.1038/bjc.1981.259.

Non-immunogenicity of enucleated rat hepatoma cells in syngeneic animals

Free PMC article
Comparative Study

Non-immunogenicity of enucleated rat hepatoma cells in syngeneic animals

D Gerlier et al. Br J Cancer. 1981 Nov.
Free PMC article

Abstract

Cytoplasts and karyoplasts were obtained by ultracentrifugation of Hepatoma D23 cells on a Ficoll gradient containing cytochalasin B. Their nuclear and protein content and their metabolic activity were determined. Three i.p. injections of 2.3 x 10(7) cytoplasts were unable to protect syngeneic WAB/Not rats against an s.c. challenge of 10(4) D23 cells, whereas a similar amount of karyoplasts, or 3 injections of 10(6) irradiated D23 cells, were fully protective. Ability of cytoplasts to act as primary or secondary immunogen were also studied, and compared to that of 0.01% glutaraldehyde-treated cells, 43 degrees C heat-treated cells and 3M KCl-soluble extracts, these preparations also being of weak immunogenicity. Only heat-treated cells behaved as a primary immunogen, whereas none of the preparations provided a secondary stimulation. Moreover, when these preparations were fed in vitro to peritoneal-exudate cells before their injection into rats, cytoplasts and glutaraldehyde-treated cells showed no immunogenicity, whereas heat-treated cells induced full protection against tumour challenge. Therefore, in this tumour model, the in vivo persistence of immunogen and the presence of a nucleus are likely to be crucial in inducing transplantation resistance to tumour.

PubMed Disclaimer

References

    1. Int J Cancer. 1967 Jul 15;2(4):355-64 - PubMed
    1. Cancer Res. 1965 May;25:451-7 - PubMed
    1. Biochem Biophys Res Commun. 1975 Apr 7;63(3):669-74 - PubMed
    1. Br J Cancer. 1975 Jul;32(1):21-7 - PubMed
    1. Br J Cancer. 1974 Nov;30(5):394-400 - PubMed

Publication types